4.17 A Novel Approach to Minimal Residual Disease Assessment in Chronic Lymphocytic Leukaemia Utilizing the Tumour Specific Antigen CD160
2007 ◽
Vol 20
(3)
◽
pp. 499-512
◽
2021 ◽
Vol 8
(12)
◽
pp. e879-e890
◽
2007 ◽
Vol 136
(3)
◽
pp. 379-392
◽
2019 ◽
Vol 6
(9)
◽
pp. e470-e479
◽
2016 ◽
Vol 176
(4)
◽
pp. 573-582
◽